Related Experiment Video

Updated: Aug 19, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

[Considerable decrease in chemokine interleukin-16 level in blood of children with diabetes mellitus type I diagnosed

V V Popova, S V Mel'nichenko, K P Zak

    Likars'Ka Sprava
    |February 24, 2005
    PubMed

    Insights

    A significant reduction in interleukin-16 (IL-16) levels was observed in the blood serum of children newly diagnosed with type 1 diabetes mellitus. This finding may offer new insights into the disease

    Area of Science:

    • Immunology
    • Endocrinology
    • Pediatrics

    Context:

    • Type 1 diabetes mellitus (T1DM) is an autoimmune disease characterized by pancreatic beta-cell destruction.
    • Chemokines play a crucial role in immune cell trafficking and inflammatory processes.
    • Interleukin-16 (IL-16) is a cytokine with known immunomodulatory functions.

    Purpose:

    • To investigate the association between serum levels of chemokine interleukin-16 (IL-16) and newly diagnosed type 1 diabetes mellitus in children.
    • To determine if IL-16 levels differ in children with T1DM compared to healthy controls.

    Summary:

    • A considerable decrease in serum chemokine interleukin-16 (IL-16) levels was detected in children experiencing their first diagnosis of type 1 diabetes mellitus.
    • This observed reduction suggests a potential role for IL-16 in the pathogenesis or as a biomarker for early-stage T1DM in pediatric populations.

    Impact:

    • Provides novel insights into the immunological underpinnings of type 1 diabetes mellitus in children.
    • Highlights interleukin-16 (IL-16) as a potential biomarker for early detection or disease monitoring in pediatric T1DM.
    • May inform future research directions for therapeutic strategies targeting IL-16 pathways in T1DM.

    Related Concept Videos

    Type I Diabetes I: Introduction01:12

    Type I Diabetes I: Introduction

    Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
    Diabetes Mellitus: Overview and Type I Subtype01:22

    Diabetes Mellitus: Overview and Type I Subtype

    Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
    Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
    Type I Diabetes II: Pathophysiology01:26

    Type I Diabetes II: Pathophysiology

    Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
    Type I Diabetes III: Clinical Manifestations01:19

    Type I Diabetes III: Clinical Manifestations

    Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
    Diabetes: Symptoms, Diagnosis, and Complications01:15

    Diabetes: Symptoms, Diagnosis, and Complications

    For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
    Diabetes Mellitus: Type 2 and Gestational01:22

    Diabetes Mellitus: Type 2 and Gestational

    Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...